AI-washing – when AI hype becomes a litigation risk
5 Pharma Ad Enforcement Trends To Watch
25 April 2014
Prescription drug promotion is suddenly in a state of tremendous flux, with the legal landscape shifting rapidly amid court decisions on free speech, the Affordable Care Act’s emphasis on value and the U.S. Food and Drug Administration’s reappraisal of how risks are disclosed. Law360 talked with experts about the upheaval, and they named five enforcement trends to follow closely.
Read more: 5 Pharma Ad Enforcement Trends To Watch
View more insights and analysis
